Literature DB >> 7575614

Apo-dystrophins (Dp140 and Dp71) and dystrophin splicing isoforms in developing brain.

G E Morris1, C Simmons, T M Nguyen.   

Abstract

PCR studies have shown that exons 71-74 are spliced out in most dystrophin mRNA transcripts in the brain. We have prepared new monoclonal antibodies against the syntrophin-binding region of dystrophin encoded by exons 73-74 and examined three protein products of the dystrophin gene in brain; the widely distributed Dp71, the recently discovered, brain-specific Dp140 and dystrophin itself. Exon 73-74 mAbs bound to all three proteins in brain and the extent of binding suggests that alternatively spliced dystrophins are less prominent at the protein level than predicted by PCR data. Dp140, unlike Dp71, was found to be present at much higher levels in foetal brain than in adult brain. If lack of functional Dp140 is the cause of the cognitive impairment in some Duchenne muscular dystrophy patients, this result suggests that the effects may occur early in development, which would reduce the options for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575614     DOI: 10.1006/bbrc.1995.2474

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis.

Authors:  Carlos Pascual-Morena; Vicente Martínez-Vizcaíno; Alicia Saz-Lara; José Francisco López-Gil; Jaime Fernández-Bravo-Rodrigo; Iván Cavero-Redondo
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 4.849

Review 2.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

3.  A defect in dystrophin causes a novel porcine stress syndrome.

Authors:  Dan J Nonneman; Tami Brown-Brandl; Shuna A Jones; Ralph T Wiedmann; Gary A Rohrer
Journal:  BMC Genomics       Date:  2012-06-12       Impact factor: 3.969

4.  Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.

Authors:  Maria Grazia D'Angelo; Maria Luisa Lorusso; Federica Civati; Giacomo Pietro Comi; Francesca Magri; Roberto Del Bo; Michela Guglieri; Massimo Molteni; Anna Carla Turconi; Nereo Bresolin
Journal:  Pediatr Neurol       Date:  2011-11       Impact factor: 3.372

5.  Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering.

Authors:  M W Cohen; C Jacobson; P D Yurchenco; G E Morris; S Carbonetto
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

Review 6.  Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.

Authors:  Anna Rugowska; Alicja Starosta; Patryk Konieczny
Journal:  Clin Epigenetics       Date:  2021-01-19       Impact factor: 6.551

7.  Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy.

Authors:  Amel Saoudi; Faouzi Zarrouki; Catherine Sebrié; Charlotte Izabelle; Aurélie Goyenvalle; Cyrille Vaillend
Journal:  Dis Model Mech       Date:  2021-09-21       Impact factor: 5.758

8.  Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.

Authors:  Peter J Taylor; Grant A Betts; Sarah Maroulis; Christian Gilissen; Robyn L Pedersen; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

9.  Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains.

Authors:  Bailey Nichols; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Brain Sci       Date:  2015-07-29

10.  Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy.

Authors:  Nathalie Doorenweerd; Ahmed Mahfouz; Maaike van Putten; Rajaram Kaliyaperumal; Peter A C T' Hoen; Jos G M Hendriksen; Annemieke M Aartsma-Rus; Jan J G M Verschuuren; Erik H Niks; Marcel J T Reinders; Hermien E Kan; Boudewijn P F Lelieveldt
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.